Detailed price information for SC Pharmaceuticals Inc (SCPH-Q) from The Globe and Mail including charting and trades.

Diabetes is rapidly becoming one of the most significant health challenges in Africa, with the continent experiencing one of the highest growth rates in diabetes prevalence globally. The condition ...

The following is a summary of “Association between triglyceride-glucose index and its composite obesity indexes and cardio-renal disease: analysis of the NHANES 2013-2018 cycle,” published in the ...

The European Commission (EC) has granted marketing authorisation to BridgeBio Pharma’s selective small molecule, acoramidis, ...

The first kidney or cardiorenal outcome trial with an SGLT2 inhibitor, CREDENCE, was done in patients with type 2 diabetes, mostly because canagliflozin (Invokana, Janssen) was already on the ...

Q4 2024 Earnings Call Transcript February 12, 2025 Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

aDivision of Nephrology, Department of Internal Medicine II, University Hospital Giessen and Marburg, Justus-Liebig-University Giessen, 35392 Giessen, Germany ...

Thank you again for joining us. This is Nihar Desai from the Yale School of Medicine, for the Medscape InDiscussion Cardiorenal Metabolic Syndrome Podcast.

Biomarkers can provide insights into underlying mechanisms and lead to a better understanding of complex disease states such as the cardiorenal syndrome, which can lead to better therapies and ...

E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, ...

Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...

More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...